Yue Ren

机构：Dana-Farber Cancer Institute · ORCID：0009-0003-4777-3342

发表论文 33 篇 · 总被引 384 次 · h-index 7

代表论文

• Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease (2024 · Journal of Clinical Oncology · 被引 40)
• Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemia (2024 · Blood Advances · 被引 7)
• A Phase 2 Study of Duvelisib and Venetoclax in Patients with Relapsed or Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Richter's Syndrome (RS) (2024 · Blood · 被引 6)
• Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor–Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study (2025 · Clinical Cancer Research · 被引 3)
• Abstract 3707: Characterization of estrogen receptor expression on CTCs during CDK4/6i treatment in HR+/HER2- metastatic breast cancer: Results from the PACE phase II study (2024 · Cancer Research · 被引 3)
• Assessment of Adjuvant Endocrine Therapy With Ovarian Function Suppression by Breast Cancer Index (2025 · JAMA Network Open · 被引 2)